| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |